Status: Recruiting
S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion
The Purpose of the study is to test the hypothesis that administration of an S-nitrosylating (SNO) agent can improve tissue oxygenation during transfusion of packed red blood cells (RBCs).
Participants needed: 35
Trial details
Phase: Phase 1Age: 18-35Biological sex: AllType: InterventionalSponsor: James ReynoldsUpdated: Dec 2, 2025Locations: 1
Eligibility criteria
Hemoglobin > 12 g/dl [+1]
Individuals who are pregnant, breastfeeding, or are unwilling to avoid pregnancy... [+9]